BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct-acting antiviral
1
Analysis of hepatitis C virus positive organs in liver transplantation.
9/23/2022 12:48:56 AM | Browse: 443 | Download: 1045
2
Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
8/10/2022 8:23:14 AM | Browse: 448 | Download: 1620
3
Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
6/23/2022 2:39:01 PM | Browse: 547 | Download: 1510
4
Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020
5/13/2022 8:46:13 AM | Browse: 412 | Download: 1213
5
Hepatitis C virus failure to treatment: Clinical utility of testing resistance associated substitutions
9/22/2021 8:09:41 AM | Browse: 591 | Download: 1458
6
Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
12/18/2020 5:58:43 AM | Browse: 712 | Download: 1525
7
Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
9/21/2020 4:02:08 PM | Browse: 662 | Download: 1664
8
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 798 | Download: 1626
9
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 1110 | Download: 2228
10
Hepatitis C virus infection in children in the era of direct-acting antiviral
6/26/2018 12:26:34 AM | Browse: 1425 | Download: 1702
11
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 1366 | Download: 2961
12
Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses
7/4/2016 2:42:00 PM | Browse: 1182 | Download: 1398
13
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 1446 | Download: 2530
14
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C
11/18/2015 11:12:00 AM | Browse: 1179 | Download: 2091
15
Immune and non-immune responses to hepatitis C virus infection
10/14/2015 12:06:00 PM | Browse: 1204 | Download: 1941
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345